KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Cash from Investing Activities (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Cash from Investing Activities readings, the most recent being -$9.0 billion for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 1600.38% to -$9.0 billion in Q1 2026 year-over-year; TTM through Mar 2026 was -$12.5 billion, a 187.71% decrease, with the full-year FY2025 number at -$4.0 billion, up 30.71% from a year prior.
  • Cash from Investing Activities hit -$9.0 billion in Q1 2026 for Thermo Fisher Scientific, down from $891.0 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $891.0 million in Q4 2025 to a low of -$9.0 billion in Q1 2026.
  • Median Cash from Investing Activities over the past 5 years was -$527.0 million (2025), compared with a mean of -$1.5 billion.
  • Biggest five-year swings in Cash from Investing Activities: skyrocketed 4355.0% in 2025 and later crashed 1600.38% in 2026.
  • Thermo Fisher Scientific's Cash from Investing Activities stood at -$525.0 million in 2022, then increased by 28.38% to -$376.0 million in 2023, then skyrocketed by 105.32% to $20.0 million in 2024, then skyrocketed by 4355.0% to $891.0 million in 2025, then plummeted by 1105.72% to -$9.0 billion in 2026.
  • The last three reported values for Cash from Investing Activities were -$9.0 billion (Q1 2026), $891.0 million (Q4 2025), and -$4.1 billion (Q3 2025) per Business Quant data.